Leonardi, Craig
182  Ergebnisse:
Personensuche X
?
2

Development of Psoriasis Assessment Tools Among Patients in..:

Gulliver, Wayne P. ; See, Kyoungah ; Zhu, Baojin...
Journal of Psoriasis and Psoriatic Arthritis.  8 (2023)  2 - p. 74-82 , 2023
 
?
3

34658 Deucravacitinib, an oral, selective tyrosine kinase 2..:

Armstrong, April W. ; Warren, Richard B. ; Sofen, Howard...
Journal of the American Academy of Dermatology.  87 (2022)  3 - p. AB156 , 2022
 
?
4

34346 Pooled safety analysis of respiratory tract infection..:

Schulze-Koops, Hendrik ; Deodhar, Atul ; Voll, Reinhard E....
Journal of the American Academy of Dermatology.  87 (2022)  3 - p. AB192 , 2022
 
?
5

34314 Bimekizumab comparative efficacy in psoriasis: Number..:

Leonardi, Craig ; Armstrong, April ; Eyerich, Kilian
Journal of the American Academy of Dermatology.  87 (2022)  3 - p. AB24 , 2022
 
?
10

Tofacitinib for the Treatment of Refractory Palmoplantar Ps..:

Muzumdar, Sonal ; Leonardi, Craig ; Strober, Bruce
Journal of Psoriasis and Psoriatic Arthritis.  6 (2021)  2 - p. 93-98 , 2021
 
?
11

Healthcare Resource Utilization and Baseline Characteristic..:

Sobell, Jeffrey M. ; Gao, Ran ; Golembesky, Amanda K....
Journal of Psoriasis and Psoriatic Arthritis.  6 (2021)  3 - p. 143-150 , 2021
 
?
12

24899 Ixekizumab sustains high efficacy and a favorable saf..:

Papp, Kim ; Blauvelt, Andrew ; Puig, Luis...
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB50 , 2021
 
?
13

Tildrakizumab efficacy, drug survival, and safety are compa..:

Lebwohl, Mark G. ; Leonardi, Craig L. ; Mehta, Nehal N....
Journal of the American Academy of Dermatology.  84 (2021)  2 - p. 398-407 , 2021
 
?
 
1-15